BTTX — Better Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
Brief: Better Therapeutics Announces Positive Primary Endpoint Data From Pivotal Clinical Trial Of BT-001, A Prescription Digital Therapeutic (PDT)
Brief: Better Therapeutics Announces New CMS HCPCS Code For Prescription Digital Behavioral Therapies (PDTS)
Brief: Better Therapeutics Enrolls First Patient In Real World Evidence Study With Colorado Prevention Center Clinical Research
U.S. STOCKS ON THE MOVE-Snap, Ford, Clorox
Brief: Better Therapeutics Appoints Deepti Sodhi Jaggi, Pharmd, As Chief Strategy Officer
Brief: Better Therapeutics Completes Enrollment Of Pivotal Trial For BT-001
Brief: Better Therapeutics Appoints Member To Board Of Directors
Better Therapeutics triples a day after SPAC merger
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:20 AM
Brief: Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination With Better Therapeutics
Brief: Better Therapeutics Expects Pivotal Trial Of BT-001 In Type 2 Diabetes To Be Fully Enrolled In Q4 2021
Brief: Better Therapeutics To Go Public via Merger with Mountain Crest Acquisition Corp II
U.S. STOCKS ON THE MOVE-Chembio Diagnostics, Gogo Inc, Bio-Path Holdings, Leaf Group